IP84-20: Discovery of a Nuclear-Active TBK1 Inhibitor Targeting Synthetic Lethality in VHL-Deficient Renal Cell Carcinoma
Monday, May 18, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)
147B
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!